Indication Global
Market Size
Pre
clinical
Phase
Ib
Phase
II/III
EU Conditional
Marketing
Approval
Post EU
Marketing
U.S. Phase III
xxxxxx
Prevention of post-Bone Marrow Transplantations (BMT) complications $3B     IIa Completed
II/III Initiation
Q1 2020
    Read More
               
Treatment of post-BMT complications for steroid refractory patients $1.3B     Phase II
Initiation
Q3 2020
    Read More
               
Adjunctive treatment for prevention of cytokine storms in Sepsis $33B   Phase Ib
Ongoing
Phase II
Initiation
Q4 2019
    Read More
               
Solid tumor “immune checkpoint” microenvironment modulating $4B   Seeking
Partner
      Read More